We’re delighted to see Made Scientific’s continued growth, marked by the announcement of a new manufacturing facility in New Jersey. Congratulations on such a major milestone! With a second expansion phase already planned, it’s exciting to see your ambitions in the cell therapy space taking shape.
For 15 years, 3P innovation has partnered with leading pharmaceutical companies, including AstraZeneca , GSK, J&J, and CDMOs across the globe to deliver complex automation and advanced pharmaceutical equipment. Our experience in this space has built a reputation for proven delivery, trusted support, and a deep understanding of the stringent standards required in cell therapy and biopharma manufacturing.
As you scale, 3P innovation is ready to support with flexible, scalable automation solutions that adapt to your exacting needs. Through our close partnership with Cellular Origins, where cryoFIL ® is part of their Constellation platform, we are helping to accelerate the industrialisation of CGT manufacturing.
We’d love the opportunity to discuss how we can help you deliver the therapies of tomorrow.
Who are we?
3P innovation creates precision-engineered automation for pharmaceutical and industrial manufacturers. Our systems are designed for:
- Scalability from lab to commercial scale
- Exacting regulatory and performance standards
- Flexible customisation for all of our pharma equipment
We know the costs of inflexible or overengineered production systems, and we understand the pressure to avoid delays or mistakes in high-stakes environments like yours.
What makes us different?
- Proof-of-Principle approach: We reduce innovation risk through early, low-cost testing that confirms feasibility before major investment.
- Tailored automation: Whether it's a modular platform or one-off bespoke system, we apply deep engineering insight to your specific product and process.
- Fast, expert support: Our service doesn’t stop at commissioning. When you need help, you get direct access to the original design engineers.
Our pharma equipment portfolio
